Dr. Andrew Vickers discusses the continuing trend of medical reseachers refusing to release raw data after publication. What impact does this make on delaying the advancement of science? Are doctors viewing these results as their personal property? Is there a danger that the public's perception will be that clinical trials are for the benefit of the scientist's career rather then the patients? Join host Dr. Maurie Pickard for an interesting discussion.
Ethical and Logistic Consequences of Closed Scientific Data

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Andrew Vickers discusses the continuing trend of medical reseachers refusing to release raw data after publication. What impact does this make on delaying the advancement of science? Are doctors viewing these results as their personal property? Is there a danger that the public's perception will be that clinical trials are for the benefit of the scientist's career rather then the patients? Join host Dr. Maurie Pickard for an interesting discussion.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
HF Management for Patients with Comorbid Conditions
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?